AIDS-Related Opportunistic Infections - Drug therapy
Research News and Information

Friday, March 19, 2010

Pharmacotherapy of cryptococcosis.

29 Sep 2009 Cryptococcus neoformans is an opportunistic fungal pathogen that causes central nervous system and pulmonary disease among immunocompromised patients. Recent studies highlight the high incidence of cryptococcosis among patients in certain ... Read more...

Cryptococcal immune reconstitution inflammatory syndrome after antiretroviral therapy in AIDS patients with cryptococcal meningitis: a prospective multicenter study.

13 Sep 2009 A prospective multicenter study of cryptococcal immune reconstitution inflammatory syndrome (IRIS) was conducted as a substudy of the Bacteriology and Mycology Study Group 3-01. Of 101 AIDS patients with cryptococcal meningitis who received highly ... Read more...

Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.

2 Sep 2009 This report updates and combines into one document earlier versions of guidelines for preventing and treating opportunistic infections (OIs) among HIV-exposed and HIV-infected children, last published in 2002 and 2004, respectively. These guidelines ... Read more...

Latest indexed articles for 'AIDS-Related Opportunistic Infections - Drug therapy'

These are the very latest articles for this heading:

• Pharmacotherapy of cryptococcosis. 29 Sep 2009
• Acute syphilitic progression in an HIV-positive patient. 29 Sep 2009
• Drugs for tuberculosis. 29 Sep 2009
• Cryptococcal immune reconstitution inflammatory syndrome after antiretroviral therapy in AIDS patients with cryptococcal meningitis: a prospective multicenter study. 13 Sep 2009
• Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics. 2 Sep 2009
• Funding. Experts look for more to fight TB, HIV/AIDS coinfection. 30 Aug 2009
• Outcome from treatment of Pneumocystis jirovecii pneumonia with co-trimoxazole. 30 Aug 2009
• Universal prophylaxis, targeted prophylaxis, and/or preemptive therapy for opportunistic infections at the time of initiation of combination antiretroviral therapy for patients with advanced HIV Infection. 30 Aug 2009
• Primary care guidelines for the management of persons infected with human immunodeficiency virus: 2009 update by the HIV medicine Association of the Infectious Diseases Society of America. 30 Aug 2009
• Independent association between rate of clearance of infection and clinical outcome of HIV-associated cryptococcal meningitis: analysis of a combined cohort of 262 patients. 30 Aug 2009
• Protein-losing enteropathy during highly active antiretroviral therapy in a patient with AIDS-related disseminated Mycobacterial avium complex infection. 16 Aug 2009
• First-line antituberculosis drug resistance prevalence and its pattern among HIV-infected patients in the national referral tuberculosis centre, Iran. 30 Jul 2009
• Disseminated herpes zoster with increased CD4 counts in 3 HIV-infected patients. 30 Jul 2009
• Interindividual variability in pharmacokinetics of generic nucleoside reverse transcriptase inhibitors in TB/HIV-coinfected Ghanaian patients: UGT2B7*1c is associated with faster zidovudine clearance and glucuronidation. 21 Jul 2009
• The whole is greater than the sum of the parts: recognising missed opportunities for an optimal response to the rapidly maturing TB-HIV co-epidemic in South Africa. 14 Jul 2009
• HIV/viral hepatitis coinfection: the Immunology Center experience. 29 Jun 2009
• What's new in the 2009 US guidelines for prevention and treatment of opportunistic infections among adults and adolescents with HIV? 29 Jun 2009
• Improved early results for patients with extensively drug-resistant tuberculosis and HIV in South Africa. 29 Jun 2009
• HIV treatment update released. 29 Jun 2009
• Guidelines: opportunistic infections and HIV patients. 29 Jun 2009

See a longer list of these articles.

Technical information about 'AIDS-Related Opportunistic Infections'

Definition: Opportunistic infections found in patients who test positive for human immunodeficiency virus (HIV). The most common include PNEUMOCYSTIS PNEUMONIA, Kaposi's sarcoma, cryptosporidiosis, herpes simplex, toxoplasmosis, cryptococcosis, and infections with Mycobacterium avium complex, Microsporidium, and Cytomegalovirus.

Descriptor UI: D017088

Alternative terms: AIDS-Related Opportunistic Infections; AIDS Related Opportunistic Infections; Opportunistic Infections, AIDS-Related; AIDS-Related Opportunistic Infection; Opportunistic Infection, AIDS-Related; Opportunistic Infections, AIDS Related; HIV-Related Opportunistic Infections; HIV Related Opportunistic Infections; HIV-Related Opportunistic Infection; Infection, HIV-Related Opportunistic; Infections, HIV-Related Opportunistic; Opportunistic Infection, HIV-Related; Opportunistic Infections, HIV-Related; Opportunistic Infections, HIV Related;

Related Mesh Headings: Toxoplasmosis, Cerebral; Meningitis, Cryptococcal;

Allowable Qualifiers: blood; cerebrospinal fluid; chemically induced; classification; complications; congenital; diagnosis; diet therapy; drug therapy; economics; embryology; enzymology; ethnology; etiology; genetics; history; immunology; metabolism; microbiology; mortality; nursing; epidemiology; parasitology; pathology; physiopathology; prevention & control; psychology; radiography; radionuclide imaging; radiotherapy; rehabilitation; surgery; therapy; transmission; urine; veterinary; ultrasonography; virology;

Tree Number: C01.539.597.050; C02.597.050; C02.782.815.616.400.100; C03.684.050; C20.673.480.100;

History Note: 93

Technical Notes: coord IM with HIV-1 or HIV-2 (IM or NIM if pertinent); coord IM with specific opportunistic infect (IM); DF: AIDS RELAT OPPORTUNISTIC INFECT